Development of Cyclodextrin-based Cancer Treatment.
In conclusion, FA-M-β-CyD has potential as a novel tumor-selective anticancer agent due to FR-α-mediated cellular uptake. The present results provide useful information for the design and development of novel antitumor drug carriers and antitumor drugs based on CyDs.
PMID: 26521878 [PubMed - in process]
Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - Category: Drugs & Pharmacology Authors: Motoyama K Tags: Yakugaku Zasshi Source Type: research
More News: Cancer | Cancer & Oncology | Cholesterol | Colon Cancer | Colorectal Cancer | Drugs & Pharmacology | Epithelial Cancer | Folic Acid | Study